IP Library Granted Patent US 10,568,567
Granted Patent B1
US 10,568,567 · App. 16/252,859 · Granted Feb 25, 2020

Method of drug approval using motion vector analysis

Inventors: Daniel J. Ford (San Francisco, CA); Jonathan Betts-Lacroix (Belmont, CA)
Assignee: Vium, Inc
A61B5/4839A61B5/0077A61B5/1113A61B5/1121G06T7/0016A61B5/4528A61B2503/40G06T2207/30004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,568,567
App. No.
16/252,859
Granted
Feb 25, 2020
Kind
B1
Abstract

A method of treating a patient for a disease, such as arthritis, is described. Steps include treating an animal for the disease with a first treatment, capturing video frames, then using optical flow to compute vector fields for each frame, then taking a maximum vector value over a first time period, then selecting a set of maximum vector values over a second time period, then clipping those values to a maximum, and then computing an average of those values. This value is an efficacy and it is compared to a baseline efficacy. If the treatment is efficacious, the patient is so treated. A method of applying for a drug for approval is also described, using substantially the same steps.

Claims (22)

1. A method for treating a patient for a first disease comprising the steps:

(a) treating an animal for a first disease using a first treatment;

(b) recording, using a camera, a series of image frames of an animal cage interior wherein the cage comprises the animal;

(c) generating a reduced vector field from at least a subset of image frames from step (b) using optical flow analysis;

(d) selecting one or more maximum vector values from the vector field from step (c);

(e) computing a first-period maximum value for the one or more maximum vector values from step (d) over a first time period length;

(f) repeating steps (b) through (e) for multiple, sequential time periods having the first time period length, wherein the multiple, sequential time periods fall within a second time period;

(g) selecting a second-period maximum value set from all of the first-period maximum values computed from repeating step (e);

(h) computing a mean value from the values of the second-period maximum value set selected from step (g);

(i) computing an efficacy of the first drug by subtracting a baseline value from the mean value from step (h);

(j) treating the patient with the first drug when the efficacy of the first drug computed in step (i) exceeds a predetermined threshold value.

2. A method for applying for approval of first drug for treating patients with a first disease, comprising the steps:

(a) treating an animal for a first disease using a first treatment;

(b) recording, using a camera, a series of image frames of an animal cage interior wherein the cage comprises the animal;

(c) generating a reduced vector field from at least a subset of image frames from step (b) using optical flow analysis;

(d) selecting one or more maximum vector values from the vector field from step (c);

(e) computing a first-period maximum value for the one or more maximum vector values from step (d) over a first time period length;

(f) repeating steps (b) through (e) for multiple, sequential time periods having the first time period length, wherein the multiple, sequential time periods fall within a second time period;

(g) selecting a second-period maximum value set from all of the first-period maximum values computed from repeating step (e);

(h) computing a mean value from the values of the second-period maximum value set selected from step (g);

(i) computing an efficacy of the first drug by subtracting a baseline value from the mean value from step (h); and

(j) applying for approval of the first drug when the efficacy of the first drug exceeds a predetermined threshold value.

Assignments (10)
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTIES NAME FROM RECURSION PHARMACEUTICALS, INC. TO VIUM (ABC) LLC AND PROPERTY NUMBERS FROM 34 TO 42 TOTAL ATTACHMENTS FROM 19 PAGES TO 9 PAGES PREVIOUSLY RECORDED ON REEL 54439 FRAME 362. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT . Recorded Mar 25, 2024
From: VIUM, INC.
To: VIUM (ABC) LLC
Reel/Frame 066893/0379 →
CHANGE OF NAME Recorded Mar 1, 2024
From: MOUSERA, INC.
To: VIUM, INC.
Reel/Frame 066724/0602 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2024
From: FORD, DANIEL
To: MOUSERA, INC.
Reel/Frame 066503/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: BETTS-LACROIX, JONATHAN
To: VIUM, INC.
Reel/Frame 066483/0971 →
CORRECTIVE ASSIGNMENT TO CORRECT THE D877354 PREVIOUSLY RECORDED AT REEL: 055620 FRAME: 0040. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SERCURITY INTEREST. Recorded Aug 4, 2021
From: SILICON VALLEY BANK
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 057086/0684 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE APPLICATION NUMBER PREVIOUSLY RECORDED AT REEL: 053047 FRAME: 0191. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 4, 2021
From: VIUM, INC.
To: SILICON VALLEY BANK
Reel/Frame 057085/0787 →
RELEASE OF SECURITY INTEREST Recorded Mar 16, 2021
From: SILICON VALLEY BANK
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 055620/0040 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 22, 2020
From: VIUM, INC.
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 054439/0362 →
NUNC PRO TUNC ASSIGNMENT Recorded Nov 22, 2020
From: VIUM, INC.
To: RECURSION PHARMACEUTICALS, INC.
Reel/Frame 054439/0387 →
SECURITY INTEREST Recorded Jun 25, 2020
From: VIUM, INC.
To: SILICON VALLEY BANK
Reel/Frame 053047/0192 →
Continuity (1)
Continuation In Part 15168489 · May 31, 2016